Amit Sachdev Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Amit Sachdev is EVP Chief Patient & Ext Af Off of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 55,325 shares of VRTX, which is worth approximately $25.9 Million. The most recent transaction as insider was on May 15, 2024, when has been sold 32 shares (Common Stock) at a price of $430.93 per share, resulting in proceeds of $13,789. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.3K

0% 3M change

5.93% 12M change

Total Value Held $25.9 Million

Amit Sachdev Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	SELL Open market or private sale	$13,789 $430.93 p/Share	32 Reduced 0.06%	55,325 Common Stock
Feb 26 2024	SELL Open market or private sale	$1,278,802 $425.7 p/Share	3,004 Reduced 5.15%	55,325 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$1,066,089 $431.79 p/Share	2,469 Reduced 4.06%	58,329 Common Stock
Feb 21 2024	SELL Open market or private sale	$1,345,868 $421.77 p/Share	3,191 Reduced 4.99%	60,798 Common Stock
Feb 20 2024	SELL Open market or private sale	$1,790,040 $420.79 p/Share	4,254 Reduced 6.23%	63,989 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$1,103,181 $420.58 p/Share	2,623 Reduced 3.7%	68,243 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$1,483,186 $424.01 p/Share	3,498 Reduced 4.7%	70,866 Common Stock
Feb 12 2024	SELL Open market or private sale	$1,354,013 $420.24 p/Share	3,222 Reduced 4.15%	74,364 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$854,780 $422.74 p/Share	2,022 Reduced 2.54%	77,586 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	7,114 Added 8.2%	79,608 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	13,680 Added 15.87%	72,494 Common Stock
Nov 15 2023	SELL Open market or private sale	$12,947 $369.92 p/Share	35 Reduced 0.06%	58,814 Common Stock
Aug 10 2023	SELL Open market or private sale	$3,510,850 $350.0 p/Share	10,031 Reduced 14.57%	58,814 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$713,548 $289.12 p/Share	2,468 Reduced 3.58%	66,518 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,024,389 $292.85 p/Share	3,498 Reduced 4.83%	68,986 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,388,996 $298.26 p/Share	4,657 Reduced 6.04%	72,484 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$768,495 $294.33 p/Share	2,611 Reduced 3.27%	77,141 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	26,400 Added 24.87%	79,752 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$1,678,872 $227.86 p/Share	7,368 Reduced 13.26%	48,210 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$813,087 $232.51 p/Share	3,497 Reduced 5.92%	55,578 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$592,210 $237.74 p/Share	2,491 Reduced 4.05%	59,075 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	29,638 Added 32.5%	61,566 Common Stock
Nov 15 2021	SELL Open market or private sale	$9,544 $187.13 p/Share	51 Reduced 0.16%	31,928 Common Stock
May 17 2021	SELL Open market or private sale	$9,739 $216.42 p/Share	45 Reduced 0.11%	40,133 Common Stock
Apr 27 2021	SELL Open market or private sale	$841,469 $216.65 p/Share	3,884 Reduced 8.82%	40,133 Common Stock

Also insider at

EIGR

Eiger BioPharmaceuticals, Inc. Healthcare

Amit Sachdev

EVP Chief Patient & Ext Af Off

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account